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Background. In 1998, there was a large outbreak of acute
glomerulonephritis in Nova Serrana, Brazil, caused by group
C Streptococcus zooepidemicus. This article reviews the char-
acteristics of the outbreak and some aspects of the patients’
follow-up.
Methods. We describe clinical characteristics of patients with
acute nephritis. Using case-control studies, we identified the
source of infection. Cultures of oropharyngeal swabs from pa-
tients were performed. Of 135 patients identified in 1998, avail-
able patients were reexamined in a prospective study after 2
and 5 years.
Results. Lancefield group C S. zooepidemicus was identified
as the causative organism and linked to the consumption of
cheese produced from unpasteurized milk. Of the original group
of 134 patients, 4 died in the acute phase and 5 (3.7%) required
chronic dialysis. After 2 years, of the 69 cases reevaluated, 94%
were adults (mean ± standard error age: 39 ± 2 years); we
found arterial hypertension in 42% (N = 27/64) of the patients,
reduced creatinine clearance (<80 mL/min/1.73 m2) in 30% (N
= 20/67), and increased microalbuminuria (>20 lg/min) in 34%
(N = 22/65). Preliminary data at 5-year follow-up suggest that
the percentage of patients with creatinine clearance lower than
60 mL/min increased from 9% to 15%.
Conclusion. This article highlights the dangers of consuming
unpasteurized dairy products. Follow-up of patients with epi-
demic poststreptococcal glomerulonephritis due to S. zooepi-
demicus show that a considerable proportion present hyperten-
sion, reduced renal function, and increased microalbuminuria.
Resumen
Introduccio´n. En 1998 hubo un importante brote epide´mico
de glomerulonefritis aguda en Nova Serrana, Brasil, causado
por un estreptococo del grupo C: Streptococcus zooepidemicus.
Este reporte revisa las caracterı´sticas del brote y algunos aspec-
tos del seguimiento de los pacientes.
Me´todos. Se describen las caracterı´sticas clı´nicas de los pa-
cientes con nefritis aguda. Usando estudios de casos-controles
se identifico´ la fuente de infeccio´n. Se realizaron cultivos de
frotis orofarı´ngeos de los pacientes. De los 134 casos identifica-
dos en 1998, los disponibles fueron reevaluados en un estudio
prospectivo a 2 y 5 an˜os.
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Resultados. El Streptococcus zooepidemicus, del grupo C de
Lancefield, fue identificado como el agente causal en relacio´n
al consumo de queso producido con leche no pasteurizada. Del
grupo original de 134 sujetos, 4 fallecieron en la fase aguda y 5
(3,7%) requirieron dia´lisis cro´nica. Despue´s de 2 an˜os, sobre 69
casos reevaluados, 94% adultos (edad 39 ± 2 an˜os); hallamos
hipertensio´n en 42% (N = 27/64) de los pacientes, reduccio´n
del clearance de creatinina (<80 mL/min./1,73m2) en 30%
(N = 20/67) y microalbuminuria (>20 lg/min.) en 34% (N
= 22/65). Datos preliminares con 5 an˜os de seguimiento sug-
ieren que el porcentaje de pacientes con clearance de creatinina
menor de 60 mL/min. aumento´ de 9% para 15%.
Conclusio´n. Este reporte destaca el riesgo asociado
al consumo de derivados de leche no pasteurizada. El
seguimiento de los pacientes con glomerulonefritis epide´mica
pos-estreptoco´cica por S. zooepidemicus evidencia que una pro-
porcio´n considerable presenta hipertensio´n, reduccio´n de la
funcio´n renal y aumento de la microalbuminuria.
In the 1950s and 1960s, large outbreaks of poststrepto-
coccal glomerulonephritis (PSGN) were reported in as-
sociation with certain strains of group A Streptococcus sp
[1–4]. Outbreaks of PSGN have been rare since the 1970s;
this may stem from either changes in the nephritogenic
potential of certain strains or changes in the susceptibil-
ity of the host. However, the incidence of PSGN remains
high in developing countries [5].
We have described a large outbreak of acute glomeru-
lonephritis (GN) that occurred between 1997 and 1998
in Nova Serrana, Brazil [6]. From December 1997 to
July 1998, 253 cases of GN were reported in the central-
western region of the state of Minas Gerais, Brazil. Most
patients resided in Nova Serrana (population 27,500), in
the regional health district of Divino´polis. The outbreak
was previously described in detail [6]. The clinical syn-
drome began with fever, headache, and myalgia, followed
by cervical adenopathy. After 7 to 10 days, patients devel-
oped GN with oliguria, hematuria, generalized edema,
and hypertension. The local investigation by Diretoria
Regional de Sau´de de Divino´polis indicated that most
patients were over 20 years of age. In the previous year,
local nephrologists had seen no adults with nephritis.
Histologic examinations of renal biopsy samples were
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consistent with postinfectious GN. Serologic assays for
cytomegalovirus, Epstein-Barr virus, arboviruses (includ-
ing dengue), coxsackie viruses B1-6, yellow fever, Rocio
virus, Andes hantavirus, Puumula virus, and Sin Nombre
virus were negative.
Etiology
To establish the cause of illness, in 1998 we assessed
recently identified patients, their household members,
and neighborhood-matched controls [6]. We defined an
outbreak-related case as nephritis with onset between
December 1997 and August 1998 in residents of Minas
Gerais, with at least 2 of the following findings: systolic
blood pressure higher than 140 mm Hg or diastolic blood
pressure higher than 90 mm Hg for adults and blood pres-
sure above the 95th percentile of the age-specific normal
limit for children; edema; and at least trace hematuria
or 30 mg/dL proteinuria. In 1998, we assessed 7 house-
holds of cases and neighborhood-matched control house-
holds. For each member of a case or control household,
we tested urine by dipstick test, measured blood pres-
sure, and collected swabs from the oropharynx and any
skin lesions for microbiologic culture. A telephone-based
case-control study was carried out to determine risk fac-
tors for nephritis. For each case, controls were matched
for age and sex [6].
Of throat specimens collected from a total of 52 individ-
uals in the household etiology study, 6 yielded Lancefield
group C Streptococcus sp, confirmed as S. zooepidemicus.
The 6 isolates came from 4 of 7 previously known patients
and from 2 children of 1 patient who yielded positive iso-
lates. Although these 2 children were not previously rec-
ognized as having nephritis, both had hematuria, protein-
uria, and hypertension. No S. zooepidemicus was isolated
from samples taken from the 21 symptom-free household
contacts of patients or the 22 control-household mem-
bers. Throat cultures from 4 additional people diagnosed
with nephritis after completion of the household study
identified S. zooepidemicus in 1 individual. Renal biopsy
tissue from all 8 patients showed proliferative and cres-
centic glomerular disease of varying severity, consistent
with PSGN.
Study of the source of contamination
Because investigators were aware that the organism
suspected of being the cause of the illness had previously
been associated with unpasteurized milk products, we fo-
cused our questions on exposure to animals and consump-
tion of diary products. We asked individuals about their
food preferences during the previous 6 months. Of these
foods, queijo fresco from family farms was the only food
to have been consumed by most patients with nephri-
tis. Queijo fresco was regularly supplied to local super-
market chains by 1 family farm, farm X in Quilombo do
Gaia, which was the largest supplier of queijo fresco in
Nova Serrana. During the team’s visit to farm X in Au-
gust 1998, 1 cow had acute mastitis and 2 had chronic
mastitis. The queijo fresco was made by mixing milk with
a bovine coagulant containing 50% pig pepsin and al-
lowing the mixture to sit for 40 to 60 minutes at room
temperature until it coagulated. The cheeses were then
placed in bags for distribution.
In August 1998, S. zooepidemicus was identified in
throat cultures from 3 individuals associated with farm
X. Two of the 3 S. zooepidemicus carriers were people
who prepared the cheese. Pulsed-field gel electrophore-
sis testing of all S. zooepidemicus isolates from the out-
break revealed a single pattern that differed from historic
isolates [6].
Therefore, S. zooepidemicus was isolated from throat
cultures of case patients, farm workers, and cheese mak-
ers. To confirm that outbreak-strain proteins were ex-
pressed during infection, we amplified and sequenced
the outbreak strain S. zooepidemicus M-like protein gene
(szp1) and documented positive case-patient serologic re-
sponse to the outbreak-specific M-like protein [7].
Local health authorities halted sale of queijo fresco
from farm X on Sept 1, 1998. Farm food handlers from
whom S. zooepidemicus was isolated were treated with
penicillin, and repeat cultures were done. No further new
cases of nephritis with the described characteristics have
been detected since December 1999.
Follow-up
In July 1998, for the purpose of epidemiologic inves-
tigation, case registration, and monitoring, we reviewed
inpatient charts for patients at the Hospital Sa˜o Jose´ in
Nova Serrana with discharge codes for nephritis from Jan-
uary to July 1998, and inpatient and outpatient charts for
the same period for patients examined by nephrologists
at Hospital Sa˜o Joa˜o de Deus in Divino´polis. These were
the 2 health services to which patients were referred. Of
152 possible cases of outbreak-related illness indicated
by the diagnostic coding of local physicians, 18 did not
meet the strict case definition. Of the 134 confirmed cases,
120 (89%) were adults, 97 (72%) were hospitalized, and
124 of 126 (98%) had edema; all had hematuria, serum
creatinine was >1.2 mg/dL in 57 of 98 (58%), and low
concentration of serum C3 complement was found in 10
of 12 (83%) cases. None had nephrotic syndrome. Re-
nal biopsy specimens obtained from 9 patients showed
diffuse proliferative glomerular disease consistent with
PSGN.
Several aspects of our follow-up strategies were previ-
ously described [8].
During 2 weeks in May 2000, we attempted to contact
all patients registered in our files (N = 134) seen during
the epidemic. Patients were visited in their homes by 2 of
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the coauthors and members of the regional health district
of Divino´polis. During the visit, a recently voided urine
sample was collected for sediment examination; a protein
dipstick test (Combur 10 Test M; Roche, Mannheim, Ger-
many) was performed; a blood sample was drawn (usu-
ally after fasting); an interim history was obtained; and
a physical examination (including patients’ height and
weight) was performed. Blood pressure was measured
with a mercury sphygmomanometer, while the patient
was in the sitting position after 5 minutes of rest. The
average of 3 measurements taken with a 1-minute inter-
val was used in the analysis. Hypertension was defined
when systolic blood pressure was higher than 140 mm Hg
or diastolic blood pressure was higher than 90 mm Hg
for adults, and when blood pressure was above the 95th
percentile of age-specific normal limit for children. The
patient was then carefully instructed on how to collect 24-
hour urine for analysis. All patients were revisited after
an interval of 2 weeks for a second 24-hour urine collec-
tion. Blood and urine samples were appropriately stored
at 4
◦
C and brought to the reference study laboratory in
Divino´polis. When examined within 1 day, urine samples
were kept at 4
◦
C; otherwise, they were frozen at −20◦C.
Urine samples from 24-hour collections were tested for
microalbuminuria and creatinine. Blood samples were
examined for serum creatinine (alkaline picrate method)
and serum urea (urease method) with a spectrophotome-
ter (E-225D, 1995; Companhia de Equipamentos de Lab-
oratorios Modernos, Sa˜o Paulo, Brazil). For the analysis
of creatinine clearance (corrected for 1.73 m2 of body sur-
face area) and microalbuminuria, the average of 2 mea-
surements obtained after a 2-week interval was used. Mi-
croalbuminuria was assessed by radioimmunoassay with
gamma counter equipment (Gamma C12, 1997; Diag-
nostic Products Corporation, Los Angeles, Calif, USA),
and values were considered abnormal if greater than 20
lg/min. Glomerular filtration rate (GFR) was considered
reduced when creatinine clearance was lower than 80
mL/min/1.73 m2.
The patients in this study had no clinical evidence or
any history indicating renal disease before the outbreak.
In May 2000, of the 134 confirmed cases of PSGN
seen in 1998, 3 had died in the acute phase of illness, 47
could not be located, 10 did not agree to undergo med-
ical reevaluation, 3 were on chronic dialysis in another
city, and 3 died of an underlying cause not related to re-
nal disease. Sixty-nine patients were reevaluated after a
mean time of 24 months (range, 20 to 27 months). These
patients did not differ from those not reexamined regard-
ing several characteristics at presentation.
Of the 134 patients, 10 required dialysis during the
acute phase of illness. Three of these died within 1
month of disease. Three recovered renal function and
stopped dialysis between 2 and 10 weeks. Four remained
on chronic dialysis. One additional patient started dialy-
Table 1. Baseline characteristics of patientsb
Characteristic N availablea
Age at onset years 39 ± 17 69
<15 4 (6)
>60 7 (10)
Sex
Female 47 (68) 69
Dialysis 5 (7) 69
Systolic blood pressure >140 mm Hg 47 (70) 67
Diastolic blood pressure >90 mm Hg 43 (64) 67
Serum creatinine mg/dL 1.6 (0.6–20.0) 55
>1.2 mg/dL 34 (62)
Values are expressed as mean ± standard deviation, median (range), or N (%).
aPatients for whom findings were reported in the medical chart.
bModified from [8].
sis for chronic renal failure 8 months after the onset of
disease.
Table 1 shows the initial characteristics during the acute
episode for the 69 patients who were reexamined. The
mean ± standard error age was 39 ± 2 years (range, 8–81
years); 94% were older than 15 years. Systolic and di-
astolic hypertension occurred in 70% and 64% of the
cases, respectively. Ten (14.5%) patients were taking
antihypertensive drugs for the treatment of previously
diagnosed hypertension on admission. Increased serum
creatinine (>1.2 mg/dL) was detected in 62% of the pa-
tients. Five patients required dialysis. Hematuria (>10
red blood cells/field 400×) was present in all patients [8].
Blood pressure measurements and laboratory param-
eters at follow-up are shown in Table 2. Two patients
remained on chronic dialysis. High systolic or diastolic
blood pressure was detected in 27 of 64 (42%) individ-
uals. Overall, 20 (29.0%) patients received antihyper-
tensive drugs. Serum creatinine was over 1.2 mg/dL in
10 of 68 (12%) patients, and creatinine clearance was
lower than 80 mL/min/1.73 m2 in 20 of 67 (30%). Hema-
turia was present in 10% of the patients. Three of 63
(5%) patients had proteinuria (trace or +) by dipstick;
none had nephrotic syndrome. Increased microalbumin-
uria was detected in 22 of 65 cases (34%). Thirty-one of
the 65 (48%) patients had reduced creatinine clearance
and/or increased microalbuminuria [8].
Patients with reduced creatinine clearance (N = 20)
were older (45±3 vs. 36±2 years, P =0.05), had more fre-
quently undergone dialysis [N = 4 (20%) vs. N = 1 (2%),
P = 0.03], presented with higher mean systolic blood pres-
sure in the acute phase of illness (174 ± 7 vs. 155 ± 3 mm
Hg, P = 0.03), and had higher median microalbuminuria
levels at follow-up (19 vs. 10 lg/min, P = 0.06) than the
group with normal creatinine clearance.
In June 2003, after a mean time of 5.4 years from the
onset of the outbreak, we attempted to contact all pa-
tients registered in our files for a new assessment using
the same methodology [9]. Creatinine clearance was es-
timated by the Cockroft and Gault formula [10]. Of the
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Table 2. Patient blood pressure and laboratory parameters at 2-year
follow-upc
Characteristic N availablea
Systolic blood pressure >140 mm Hg 25 (39) 64
Diastolic blood pressure >90 mm Hg 21 (33) 64
High blood pressureb 27 (42) 64
Serum creatinine >1.2 mg/dL 10 (12) 68
Creatinine clearance mL/min 90 (48–133)
<80 mL/min. 20 (30) 67
Proteinuria >150 mg/24 h 3 (5) 63
Median (range) microalbuminuria lg/min 3.5 (1–2144)
>20 lg/min 22 (34) 65
Values are expressed as mean ± SD, median (range), or N (%).
aNumber of patients with available information
bSystolic blood pressure >140 mm Hg, diastolic blood pressure >90 mm Hg,
or normal blood pressure with the use of antihypertensive drug.
cModified from [8].
134 confirmed patients with PSGN seen in 1998, 3 had
died in the acute phase of illness, 4 patients died of an
underlying cause not related to renal disease, 4 died on
chronic dialysis program, 53 could not be located, 13 did
not agree to undergo medical reevaluation or had incom-
plete data in the evaluation, and 1 was on chronic dialysis.
Fifty-six patients were reevaluated after a mean time of
65 months (range, 61 to 67 months).
Preliminary data at 5.4 years of follow-up indicated
that high blood pressure was detected in 17 of 56 (30%)
individuals [9]. Creatinine clearance was lower than 60
mL/min in 8 of 53 (15%) patients. Four of 52 (8%) pa-
tients had proteinuria (+ or more) by dipstick; none had
nephrotic syndrome. Comparing the same patients at 2
years of follow-up and at this evaluation (N = 53), the
number of patients with estimated creatinine clearance
values lower than 60 mL/min increased from 5 (9%) to 8
(15%), respectively.
DISCUSSION
S. equi subspecies zooepidemicus is rare in humans but
is a well-known cause of disease in cows and horses [11].
In humans, S. zooepidemicus can cause PSGN [12] and
other syndromes [13–16]. Four previous outbreaks at-
tributed to S. zooepidemicus have been reported, with
illness presenting as PSGN in 2 [12, 17], and as sepsis or
meningitis in the other 2 [18, 19]. Consumption of un-
pasteurized milk or milk products was implicated as the
source of infection in all 4 outbreaks.
Unlike the more common PSGN attributed to group
A Streptococcus, which affects children, this and other
outbreaks of GN due to S. zooepidemicus have predomi-
nantly affected adults [12, 17]. There is no explanation for
the unusual age distribution seen in GN caused by this mi-
croorganism. Different patterns of cheese consumption
did not seem to account for the higher attack rates among
adults. Host factors such as age-related immunologic sus-
ceptibility may have contributed to the onset of PSGN in
Nova Serrana.
The largest previous outbreak associated with S.
zooepidemicus occurred in Romania in 1968 [17]. Of 85
patients (87% adults) with sore throat and lymphadeni-
tis, one third developed GN. In another report, 3 cases
of nephritis after mild upper respiratory tract infection
occurred in members of a family in North Yorkshire,
United Kingdom [12]. Previous reports of acute PSGN
have usually been associated with group A Streptococcus
[1, 2, 4, 20]. Of these, 3 large epidemic episodes, mainly
in children, have been well described. In 1953, in Red
Lake, Minnesota, 63 cases of PSGN were reported [1,
21]. In Trinidad, from 1964 to 1966, there were 760 cases
of PSGN [2, 22]. In Maracaibo, Venezuela, in 1968, 384
cases were reported [20, 23]. Complete recovery occurred
in the great majority of cases after 10 years of follow-up.
In the present outbreak of GN, illness was severe at
presentation. During follow-up, hypertension and uri-
nary abnormalities were more frequently detected in this
series than in other outbreaks of PSGN associated with
group A Streptococcus [20–23]. It was noteworthy that
high rates of hypertension, comparable with those re-
ported for epidemic PSGN [22], were observed during
follow-up. However, at least 2 other series of sporadic
PSGN in adults have reported high rates of hyperten-
sion, 29% [24] and 42% [25], respectively, after more than
2 years of follow-up. The prevalence of hypertension dur-
ing follow-up was clearly higher than would be expected
for adults in Brazil (18%) [26].
Although overt proteinuria was uncommon and no pa-
tients had nephrotic syndrome, microalbuminuria was de-
tected in 34% of patients at 2 years’ follow-up. Microalbu-
minuria correlated with high blood pressure at follow-up.
After 2 years, reduced GFR as measured by creati-
nine clearance was detected in 30% of the patients and
was associated with an older age requirement for dialysis
and higher systolic blood pressure at presentation. Five
patients required chronic dialysis since onset of disease
(3.7%). In the literature, although short-term prognosis
of GN caused by group A Streptococci is excellent, with
early mortality rate being close to 0.5% [5], long-term
prognosis has remained controversial. Several research
groups reported a very good long-term prognosis mainly
in epidemic cases [21, 22] and in children [27, 28]. The
chance of having ESRD has been less than 1% in 10 years
[5]. Medium- to long-term prognosis in adults with spo-
radic PSGN seems to be less favorable [20, 25, 29]. In a
recent, thorough literature review [30], the proportion of
adult patients with chronic abnormalities in a series with
more than 4 years of follow-up ranges up to 36%.
There are a number of difficulties and possible biases in
the comparison of follow-up studies of PSGN. The studies
have included both episodic and epidemic disease as well
as patients with a variety of social, geographic, and ethnic
S-136 Sesso and Pinto: Epidemic nephritis
backgrounds, variable rates of hospitalization, degrees
of proteinuria, and severity at presentation. Moreover,
different criteria may have been used to define PSGN
and progression to chronicity. Renal biopsy is usually not
performed if patients do not have clinical/laboratory ab-
normalities. Reliable methods of GFR measurement and
sensitive indicators of glomerular impairment have not
always been used.
The case ascertainment methods used in the earlier
phase of the present outbreak would not have identified
most illness that did not result in hospital admission or re-
ferral to a nephrologist. Therefore, we may have studied
cases with more severe symptoms and presentation.
This outbreak highlights the dangers of consuming un-
pasteurized dairy products and the need for global efforts
to promote food safety. Moreover, after a mean follow-
up of 5.4 years, a considerable percentage of patients
with epidemic PSGN due to S. zooepidemicus continue to
present reduced renal function and hypertension. Longer
follow-up of this cohort will be important to assess the
possibility of progressive renal disease.
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